Pfizer Inc. Files 8-K on Shareholder Vote Matters
Ticker: PFE · Form: 8-K · Filed: Apr 29, 2024 · CIK: 78003
| Field | Detail |
|---|---|
| Company | Pfizer Inc (PFE) |
| Form Type | 8-K |
| Filed Date | Apr 29, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-vote, corporate-governance
Related Tickers: PFE
TL;DR
Pfizer's voting on something important, details to come.
AI Summary
On April 25, 2024, Pfizer Inc. filed an 8-K report detailing a submission of matters to a vote of security holders. The filing does not contain specific details about the vote itself, the proposals, or the outcome, but indicates that a shareholder vote is scheduled or has occurred.
Why It Matters
This filing signals that Pfizer is engaging in a formal process of seeking shareholder approval or input on significant corporate decisions, which could impact the company's future direction.
Risk Assessment
Risk Level: low — The filing is procedural and does not disclose any immediate financial or operational risks.
Key Players & Entities
- Pfizer Inc. (company) — Registrant
- April 25, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 13-5315170 (identification_number) — I.R.S. Employer Identification No.
- 66 Hudson Boulevard East (address) — Principal executive offices
- New York, New York (location) — Principal executive offices
- 10001-2192 (zip_code) — Principal executive offices
- ( 212 ) 733-2323 (phone_number) — Registrant's telephone number
FAQ
What specific matters are being submitted for a vote of Pfizer's security holders?
The filing does not specify the exact matters being submitted for a vote; it only states that such matters are being presented.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on April 25, 2024.
What is Pfizer Inc.'s principal executive office address?
Pfizer Inc.'s principal executive office is located at 66 Hudson Boulevard East, New York, New York, 10001-2192.
What is Pfizer Inc.'s I.R.S. Employer Identification Number?
Pfizer Inc.'s I.R.S. Employer Identification Number is 13-5315170.
Under which section of the Securities Exchange Act of 1934 is this Form 8-K filed?
This Form 8-K is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Stats: 769 words · 3 min read · ~3 pages · Grade level 10.7 · Accepted 2024-04-29 10:19:15
Filing Documents
- pfe-20240425.htm (8-K) — 64KB
- 0000078003-24-000101.txt ( ) — 225KB
- pfe-20240425.xsd (EX-101.SCH) — 3KB
- pfe-20240425_def.xml (EX-101.DEF) — 15KB
- pfe-20240425_lab.xml (EX-101.LAB) — 27KB
- pfe-20240425_pre.xml (EX-101.PRE) — 16KB
- pfe-20240425_htm.xml (XML) — 4KB
07 Submission of Matters to a Vote of Security Holders
Item 5.07 Submission of Matters to a Vote of Security Holders (a) The Pfizer Inc. (the "Company") Annual Meeting of Shareholders was held on April 25, 2024. (b) Shareholders voted on the matters set forth below. 1. The nominees for election to the Company's Board of Directors set forth in Item 1 to the Company's Proxy Statement filed with the U.S. Securities and Exchange Commission on March 14, 2024 were elected to hold office until the Company's next Annual Meeting of Shareholders, based upon the following votes: Nominee Votes For Votes Against Abstentions Broker non-vote Ronald E. Blaylock 3,611,209,480 74,828,190 16,147,043 893,428,132 Albert Bourla 3,416,127,786 272,930,253 13,129,674 893,428,132 Susan Desmond-Hellmann 3,609,882,463 76,819,517 15,485,733 893,428,132 Joseph J. Echevarria 3,534,360,661 151,136,693 16,687,322 893,428,132 Scott Gottlieb 3,641,520,694 46,699,897 13,967,122 893,428,132 Helen H. Hobbs 3,559,147,586 127,638,461 15,401,666 893,428,132 Susan Hockfield 3,640,156,517 46,187,757 15,843,439 893,428,132 Dan R. Littman 3,602,649,863 83,205,522 16,332,328 893,428,132 Shantanu Narayen 3,624,752,522 61,360,816 16,074,375 893,428,132 Suzanne Nora Johnson 3,509,903,128 174,627,508 17,657,077 893,428,132 James Quincey 3,608,797,590 76,444,804 16,945,319 893,428,132 James C. Smith 3,566,491,624 117,466,325 18,229,764 893,428,132 2. The proposal to ratify the selection of KPMG LLP as the Company's independent registered public accounting firm for the 2024 fiscal year was approved based upon the following votes: Votes for approval 4,315,675,552 Votes against 256,738,678 Abstentions 23,201,615 Broker non-votes n/a 3. The proposal to approve the Amended and Restated Pfizer Inc. 2019 Stock Plan was approved based upon the following votes : Votes for approval 3,405,629,196 Votes against 275,998,451 Abstentions 20,560,066 Broker non-votes 893,428,132 4. The proposal to approve, on an advisory basis, the compens
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PFIZER INC. Dated: April 29, 2024 By: /s/ Margaret M. Madden Margaret M. Madden Senior Vice President and Corporate Secretary Chief Governance Counsel